·¨¹ú£¬£¬£¬£¬£¬£¬£¬£¬¿ËÀÂí¶û——¿ËÈÕ£¬£¬£¬£¬£¬£¬£¬£¬Î¢´´Ò½ÁÆ¿ÆÑ§ÓÐÏÞ¹«Ë¾£¨00853.HK£¬£¬£¬£¬£¬£¬£¬£¬ÒÔϼò³Æ“΢´´®¼¯ÍÅ”£©ÆìÏÂ×Ó¹«Ë¾Î¢´´®ÐÄÂÉÖÎÀí£¨MicroPort® CRM£©Ðû²¼£¬£¬£¬£¬£¬£¬£¬£¬ÆäÖ²ÈëʽÐÄÂÉת¸´³ý²üÆ÷£¨ICD£©Ulys™ºÍEdis™ÒÔ¼°ÐÄÔàÔÙͬ²½³ý²üÆ÷£¨CRT-D£©Gali™ºÍGali SonR™»ñµÃÇкÏMRI£¨´Å¹²Õñ³ÉÏñ£©Ìõ¼þÇå¾²ÐÔµÄÅ·ÃË×îÐÂÒ½ÁÆÆ÷е¹æÔò£¨MDR-2017/745£©CEÈÏÖ¤¡£¡£¡£¡£¡£¡£¡£
´Ë´Î»ñÖ¤Òâζ×ÅËùÓÐÇкÏÌõ¼þµÄUlys™¡¢Edis™ºÍGali™²úÆ·£¬£¬£¬£¬£¬£¬£¬£¬°üÀ¨ÔÚ»ñµÃMRIÌõ¼þÇå¾²ÐÔÉóÅúǰÉÏÊеġ¢ÌØÊâÊÇÔÚApolloÁÙ´²Ñо¿ÖÐÅäºÏInvicta³ý²üµç¼«µ¼ÏßÖ²ÈëµÄ²úÆ·£¬£¬£¬£¬£¬£¬£¬£¬¶¼ÇкÏ1.5TºÍ3T´Å¹²ÕñÌõ¼þÇå¾²ÐÔ¡£¡£¡£¡£¡£¡£¡£ÕâЩ²úÆ·¶¼¾ßÓÐAutoMRI™ÊÖÒÕ£¬£¬£¬£¬£¬£¬£¬£¬´ËÏîÊÖÒÕÁî²úƷ̽²âµ½MRI×°±¸µÄ´Å³¡ºó£¬£¬£¬£¬£¬£¬£¬£¬×Ô¶¯¿ªÆôMRI¼ì²éģʽ£¬£¬£¬£¬£¬£¬£¬£¬²¢ÔÚÍÑÀëMRI×°±¸ºó£¬£¬£¬£¬£¬£¬£¬£¬×Ô¶¯¹Ø±ÕMRI¼ì²éģʽ[1] ¡£¡£¡£¡£¡£¡£¡£2021Äê6Ô£¬£¬£¬£¬£¬£¬£¬£¬ÓÃÓÚÆÀ¹ÀInvicta³ý²üµç¼«µ¼ÏßÇå¾²ÐÔºÍÓÐÓÃÐÔµÄÉÏÊÐǰÁÙ´²Ñо¿ÏîÄ¿ApolloÏîÄ¿ÕýʽÆô¶¯¡£¡£¡£¡£¡£¡£¡£
ICDÊÊÓÃÓÚÐÄÔàâ§ËÀΣº¦½Ï¸ßµÄ»¼Õߣ¬£¬£¬£¬£¬£¬£¬£¬Äܹ»Ò»Á¬¼à²âÐÄÂɲ¢×ÊÖú¾ÀÕý¿ìËÙÐÔÐÄÂÉʧ³£ÒÔ¼°¿ÉÄÜ»áΣ¼°ÉúÃüµÄÆäËûÐĵçÎÊÌâ¡£¡£¡£¡£¡£¡£¡£ICDÄܹ»Í¨¹ý¸ßƵ³¬ËÙÆð²«À´×èÖ¹Ò»Á¬ÐÔÊÒÐÔÐ͝¹ýËÙ£¨ÐÄÌø¿ì£©£¬£¬£¬£¬£¬£¬£¬£¬²¢ÇÒÔÚÐ͝¹ý»º£¨ÐÄÌøÂý£©Ê±×÷Ϊ“ºó±¸”ʵÁ¦À´Æð²«ÐÄÔà¡£¡£¡£¡£¡£¡£¡£ÁôÉñÔàµÄµçÔ˶¯¶ñ»¯ÎªÊÒ²üʱ£¬£¬£¬£¬£¬£¬£¬£¬ICD»¹ÄÜͨ¹ý³ý²üµ¼ÏßÊͷŸßÄÜÁ¿µç»÷£¬£¬£¬£¬£¬£¬£¬£¬Ê¹ÐÄÌøÔÚÊýÃëÄÚת¸´ÎªÕý³£ÐÄÂÉ¡£¡£¡£¡£¡£¡£¡£CRT-DÔòÅ䱸ÁËÒ»¸ùÌØÁíÍâÆð²«µ¼Ïߣ¬£¬£¬£¬£¬£¬£¬£¬¿Éͬʱ´Ì¼¤×óÓÒÐÄÊÒ£¬£¬£¬£¬£¬£¬£¬£¬ÊÊÓÃÓÚ×óÓÒÐÄÊÒËõ¶Ì²î±ð²½µÄÐÄË¥»¼Õß¡£¡£¡£¡£¡£¡£¡£Î¢´´®ÐÄÂÉÖÎÀíµÄICDºÍCRT-D½ÓÄÉÁËÏȽøÊÖÒÕ£¬£¬£¬£¬£¬£¬£¬£¬ºÄµçÁ¿µÍ£¬£¬£¬£¬£¬£¬£¬£¬ÓëÆäËû²úÆ·Ïà±È£¬£¬£¬£¬£¬£¬£¬£¬ÓµÓиü³¤µÄÔ¤¼ÆÊ¹ÓÃÊÙÃü——ICDʹÓÃÊÙÃü×î¶à¿ÉÌØÊâÑÓÉì8Ä꣬£¬£¬£¬£¬£¬£¬£¬CRT-DʹÓÃÊÙÃüÌØÊâÑÓÉì5Äê[2]¡£¡£¡£¡£¡£¡£¡£
Gali SonR™½ÓÄÉÆæÒìµÄ´«¸ÐÆ÷À´ÕÉÁ¿×óÐÄÊÒµÄËõ¶ÌÁ¦£¬£¬£¬£¬£¬£¬£¬£¬Ê¹ÔÙͬ²½ÁÆ·¨Äܹ»Ò»Ö±Ë³Ó¦Ã¿Î»»¼ÕߵIJî±ðÐèÇ󡣡£¡£¡£¡£¡£¡£¾ÁÙ´²ÑéÖ¤£¬£¬£¬£¬£¬£¬£¬£¬SonR™Ëã·¨¿ÉʹÐÄ˥סԺΣº¦ïÔÌ35%[3]¡£¡£¡£¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬£¬£¬Ë«Ç»ICD Ulys™ºÍGali™£¬£¬£¬£¬£¬£¬£¬£¬ÒÔ¼°CRT-D Gali™¶¼½ÓÄÉÁËPARAD+¡¢ÐÄÂÉʧ³£ÅбðÕï¶ÏËã·¨£¬£¬£¬£¬£¬£¬£¬£¬Æä²»Êʵ±µç»÷ÂÊΪÓÐÊ·ÒÔÀ´×îµÍ[4]¡£¡£¡£¡£¡£¡£¡£
΢´´®ÐÄÂÉÖÎÀí×ܲÃBenoît ClinchampsÌåÏÖ£º“΢´´®ÐÄÂÉÖÎÀíÒ»Ö±ÖÂÁ¦ÓÚÑз¢¼ÈÄÜÕü¾ÈÉúÃü£¬£¬£¬£¬£¬£¬£¬£¬ÓÖÄÜʹҽÉúºÍ»¼ÕßÊÜÒæµÄÏȽøÒ½ÁÆ×°±¸¡£¡£¡£¡£¡£¡£¡£ÎÒÃÇʼÖÕÇмÇÕâÒ»ÔÊÐí£¬£¬£¬£¬£¬£¬£¬£¬Æð¾¢Ê¹Ulys™¡¢Edis™ºÍGali™MRIÌõ¼þ¶Ô¼°¸ñÉèÖþßÓпÉ×·ËÝÐÔ¡£¡£¡£¡£¡£¡£¡£Äܹ»×öµ½ÕâÒ»µã£¬£¬£¬£¬£¬£¬£¬£¬ÊÇÁîÈ˺ÜÊÇÖª×ãµÄ¡£¡£¡£¡£¡£¡£¡£”
²Î¿¼×ÊÁÏ£º
[1]¡¶Î¢´´®ÐÄÂÉÖÎÀíMRI½â¾ö¼Æ»®Êֲᡷ¿ÉÔÚmicroportmanuals.comÉÏÔÚÏß»ñÈ¡
[2] Munawar D.A., et al. Predicted longevity of contemporary cardiac implantable electronic devices: A call for industry-wide « standardized » reporting. Heart Rhythm 2018;15(12):1756-63.
[3] Brugada J., et al. Contractility sensor guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur. Heart J 2017; 38(10):730-8
[4] Ruiz-Granell R., et al. Algorithm-based reduction of inappropriate defibrillator shock: results of the Inappropriate Shock Reduction with PARAD+ Rhythm Discrimination-Implantable Cardioverter Defibrillator Study. Heart Rhythm 2019; 16(9):1429-35.







Òþ˽Õþ²ß | Ö´·¨ÉùÃ÷ | ÕÐÏÍÄÉÊ¿ | ÁªÏµlzyq88¹ÙÍø | ÍøÒ³°æÓÊÏä
?Copyright 1998-2026, lzyq88¹ÙÍø. All rights reserved. ÊÖÒÕÖ§³Ö£ºÎ¨Òý»¥¶¯ | ÍøÕ¾±¸°¸/ÔÊÐíÖ¤ºÅ£º»¦ICP±¸2023023560ºÅ
»¦¹«Íø°²±¸ 31011502014876ºÅ
»¥ÁªÍøÒ©Æ·ÐÅϢЧÀÍ×ʸñÖ¤Êé±àºÅ£º£¨»¦£©- ·Çı»®ÐÔ - 2016 - 0131
¡°Î¢´´¡±¡¢¡°MicroPort¡±¼°¡°
¡±ÎªÎÒ˾ע²áÉ̱꣬£¬£¬£¬£¬£¬£¬£¬Î´¾ÔÊÐí²»µÃ˽×ÔʹÓᣡ£¡£¡£¡£¡£¡£
